MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Common stock issuance, net
Depreciation and amortization
Impairment charges
Others
Negative Cash Flow Breakdown
Repayments of debt-A2025Credit A...
Acquisitions of real estate
Repurchase of preferred stock
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-5,386
-4,281
-22,804
-12,532
Depreciation and amortization
17,811
17,738
17,987
18,029
Amortization of deferred financing costs
-
-
-
740
Amortization of deferred financing costs and mortgage discounts (premiums)
1,058
1,044
4,753
-
Accretion of terminated swap
-1,492
-1,476
-344
0
Amortization of mortgage premiums and discounts, net
-
-
-
21
(accretion) amortization of market lease and other intangibles, net
-146
-147
-131
-174
Bad debt expense
-
-
-
44
Equity-based compensation amortization expense
1,615
612
1,863
1,333
Loss (gain) on non-designated derivative instruments
-
-
-26
-77
(gain) loss on sale of real estate investments
-
-
-467
626
Gain on sale of real estate investments
0
0
-
-
Cash received from non-designated derivative instruments
233
375
683
834
Gain on non-designated derivative instruments
229
-87
-
-
Impairment charges
3,780
0
11,162
6,641
Gain on extinguishment of debt
0
-
0
0
Deferred tax valuation allowance
43
79
-496
-269
Straight-line rent receivable, net
168
268
-3,767
754
Prepaid expenses and other assets, net
-360
-597
-10,847
5,165
Termination fees payable to related parties
-
-
-
0
Accounts receivable, net
-2,032
-59
7,790
-930
Accounts payable, accrued expenses and other liabilities
3,098
-2,188
-5,382
578
Deferred leasing costs
1,029
738
899
959
Deferred rent
113
-2,322
-983
883
Net cash provided by (used in) operating activities
21,607
9,013
9,959
10,169
Acquisitions of real estate
98,031
-
0
250
Capital expenditures
5,344
5,265
11,773
4,588
Investments in non-designated interest rate caps, net
0
154
1,379
0
Proceeds from sales of real estate, net
0
0
9,821
1,581
Net cash (used in) provided by investing activities
-103,375
-5,419
-3,331
-3,007
Borrowings/proceeds from credit facility-Credit Agreement
-
-
336,000
-
Borrowings/proceeds from credit facility-Fannie Mae Secured Debt
-
-
0
-
Repayments of fannie mae secured debt
-
1,442
1,442
1,441
Repayments of debt-A2025Credit Agreement
186,000
-
-
-
Proceeds from fannie mae and other secured debt
-
-
-
0
Proceeds from mortgage notes payable
-
-
0
-
Repayments of debt-Fannie Mae Secured Debt
2,885
-
-
-
Repayments of mortgage notes payable
222
221
330,468
216
Proceeds from interest rate swap terminations
-
0
8,259
-
Payments of deferred financing costs
187
-
6,006
0
Proceeds from promissory note
-
-
0
0
Taxes paid for net settlement of equity-based awards
0
444
612
-
Payment of offering costs
3,950
-
1,217
-
Common stock issuance, net
499,422
-
-
-
Repurchase of preferred stock
25,610
-
920
2,765
Distributions paid on preferred stock-Series ACumulative Redeemable Perpetual Preferred Stock
1,772
1,773
1,771
1,776
Contributions from non-controlling interest holders
-
-
0
-
Distributions paid on preferred stock-Series BCumulative Redeemable Perpetual Preferred Stock
1,522
1,521
1,512
1,552
Distributions to non-controlling interest holders
46
46
45
46
Purchase of non-controlling interest
1,125
-
978
-
Net cash provided by (used in) financing activities
277,545
-5,447
-712
-7,796
Net change in cash, cash equivalents and restricted cash
195,777
-1,853
5,916
-634
Cash, cash equivalents and restricted cash, beginning of period
102,536
102,536
-
74,095
Cash, cash equivalents and restricted cash, end of period
302,376
106,599
-
102,536
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Common stock issuance,
net
$499,422K
Depreciation and
amortization
$17,811K
(-57.84%↓ Y/Y)
Impairment charges
$3,780K
(-86.06%↓ Y/Y)
Accounts payable,
accrued expenses and...
$3,098K
(108.51%↑ Y/Y)
Accounts receivable, net
-$2,032K
(41.29%↑ Y/Y)
Equity-based compensation
amortization expense
$1,615K
(183.33%↑ Y/Y)
Amortization of deferred
financing costs and...
$1,058K
Prepaid expenses and
other assets, net
-$360K
(-118.09%↓ Y/Y)
Cash received from
non-designated derivative...
$233K
(-86.87%↓ Y/Y)
Deferred rent
$113K
(-94.69%↓ Y/Y)
Net cash provided by
(used in) financing...
$277,545K
(918.91%↑ Y/Y)
Net cash provided by
(used in) operating...
$21,607K
(263.98%↑ Y/Y)
Canceled cashflow
$223,319K
Canceled cashflow
$8,493K
Net change in cash,
cash equivalents and...
$195,777K
(573.35%↑ Y/Y)
Canceled cashflow
$103,375K
Repayments of
debt-A2025Credit Agreement
$186,000K
Repurchase of preferred
stock
$25,610K
(1373.53%↑ Y/Y)
Payment of offering
costs
$3,950K
Repayments of debt-Fannie
Mae Secured Debt
$2,885K
Distributions paid on
preferred stock-Series...
$1,772K
(-51.24%↓ Y/Y)
Distributions paid on
preferred stock-Series...
$1,522K
(-52.44%↓ Y/Y)
Purchase of
non-controlling interest
$1,125K
Repayments of mortgage
notes payable
$222K
(-48.25%↓ Y/Y)
Payments of deferred
financing costs
$187K
(-8.78%↓ Y/Y)
Distributions to
non-controlling interest...
$46K
(-50.54%↓ Y/Y)
Net loss
-$5,386K
(75.90%↑ Y/Y)
Accretion of terminated
swap
-$1,492K
Deferred leasing costs
$1,029K
(-83.46%↓ Y/Y)
Gain on
non-designated derivative...
$229K
(638.71%↑ Y/Y)
Straight-line rent
receivable, net
$168K
(-89.87%↓ Y/Y)
(accretion) amortization of
market lease and other...
-$146K
(-106.65%↓ Y/Y)
Deferred tax valuation
allowance
$43K
(104.55%↑ Y/Y)
Net cash (used in)
provided by investing...
-$103,375K
(-235.76%↓ Y/Y)
Acquisitions of real estate
$98,031K
Capital expenditures
$5,344K
(-56.78%↓ Y/Y)
Buy us a coffee
National Healthcare Properties, Inc. (HLTC)
National Healthcare Properties, Inc. (HLTC)